Effects of arachidonic acid and docosahexaenoic acid on differentiation and mineralization of MC3T3-E1 osteoblast-like cells

Cell Biochemistry and Function

Volumn 27, Issue 1, 2009, Pages 3-11

  Coetzee, Magdalena ^a   Haag, Marianne ^a   Kruger, Marlena C ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Adipogenesis; Alkaline phosphatase activity; Arachidonic acid; Docosahexaenoic acid; Mineralization; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; PROSTAGLANDIN E2; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; LONG TERM EXPOSURE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

ADIPOCYTES; ALKALINE PHOSPHATASE; ANIMALS; ARACHIDONIC ACID; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; OSTEOBLASTS; OSTEOGENESIS; TIME FACTORS;

ANIMALIA;

EID: 60649114118     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1526     Document Type: Article

References (58)

1. Coetzer H, Claassen N, van Papendorp DH, Kruger MC. Calcium transport by isolated brush border and basolateral membrane vesicles: role of essential fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1994; 50: 257-266.
2. Watkins BA, Li Y, Lippman HE, Feng S. Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 2003; 68: 387-398.
3. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003; 18: 1206-1216.
4. Claassen N, Potgieter HC, Seppa M, Vermaak WJH, Coetzer H, van Papendorp DH, Kruger MC. Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone 1995; 16: 385S-392S.
5. Schlemmer CK, Coetzer H, Claassen N, Kruger MC. Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. Prostaglandins Leukot Essent Fatty Acids 1999; 61: 381-390.
6. Fernandes G, Lawrence R, Sun D. Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot Essent Fatty Acids 2003; 68: 361-372.
7. Mollard RC, Kovacs HR, Fitzpatrick-Wong SC, Weiler HA. Low levels of dietary arachidonic acid and docosahexaenoic acid improve bone mass in neonatal piglets, but higher levels provide no benefit. J Nutr 2005; 135: 505-512.
8. Weiss LA, Barrett-Connor E, von Mühlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo study. Am J Clin Nutr 2005; 81: 934-938.
9. Kruger MC, Horrobin DF. Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res 1997; 36: 131-151.
10. Das UN. Essential fatty acids and osteoporosis. Nutrition 2000; 16: 386-390.
11. Kettler DB. Can manipulation of the ratios of essential fatty acids slow the rapid rate of postmenopausal bone loss? Altern Med Rev 2001; 6: 61-77.
12. Van Papendorp DH, Coetzer H, Kruger MC. Biochemical profile of osteoporotic patients on essential fatty acid supplementation. Nutr Res 1995; 15: 325-334.
13. Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging Clin Exp Res 1998; 10: 385-394.
14. 1-3. Am J Clin Nutr 2007; 85: 803-807.
15. Wu LNY, Genge BR, Kang MW, Arsenault AL, Wuthier RE. Changes in phospholipids extractability and composition accompany mineralization of chicken growth plate cartilage matrix vesicles. J Biol Chem 2002; 277: 5126-5133.
16. 2 production, insulin-like growth factor-1 concentration and formation rate in chicks. J Nutr 1997; 127: 1084-1091.
17. 2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1991; 128: 2895-2900.
18. 2 production by arachidonic acid, oestrogen and parathyroid hormone in MG-63 and MC3T3-E1 osteoblast-like cells. Prostaglandins, Leukot Essent Fatty Acids 2005; 73: 423-430.
19. Stein GS, Lian JB. Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993; 14: 424-442.
20. Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990; 143: 420-430.
21. Rosa AL, Beloti MM. TAK-778 enhances osteoblast differentiation of human bone marrow cells. J Cell Biochem 2003; 89: 1148-1153.
22. 3 and dexamethasone in vitro. J Cell Physiol 2002; 193: 164-172.
23. Diascro DD, Vogel RL, Johnson TE, et al. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 1998; 13: 96-106.
24. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002; 143: 2376-2384.
25. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 1998; 13: 371-382.
26. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995; 83: 803-812.
27. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995; 83: 813-819.
28. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPARγ-2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell 2004; 3: 379-389.
29. 2 on cell proliferation and morphology of MG-63 and MC3T3-E1 osteoblast-like Cells. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 35-45.
30. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992; 7: 683-692.
31. Sudo H, Kodama H-A, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96: 191-198.
32. Bodine PVN, Trailsmith M, Komm BS. Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res 1996; 11: 806-819.
33. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 1995; 270: 9420-9428.
34. Atmani H, Chappard D, Basle MF. Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J Cell Biochem 2003; 89: 364-372.
35. Herbertson A, Aubin JE. Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J Bone Miner Res 1995; 10: 285-294.
36. Porter RM, Huckle WR, Goldstein AS. Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem 2003; 90: 13-22.
37. Weiler HA, Fitzpatrick-Wong SC. Dietary long-chain polyunsaturated fatty acids minimize dexamethasone-induced reductions in arachidonic acid status but not bone mineral content in piglets. Pediatr Res 2002; 51: 282-289.
38. Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 1995; 219: 211-222.
39. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986; 159: 109-113.
40. Feuerbach D, Loetscher E, Buerki K, Sampath TK, Feyen JHM. Establishment and characterization of conditionally immortalized stromal cell lines from a temperature-sensitiveT-Ag transgenic mouse. J Bone Miner Res 1997; 12: 179-190.
41. Yang X, Tare RS, Partridge KA, et al. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotropin: osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res 2003; 18: 47-57.
42. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER)α or β. Endocrinology 2002; 143: 2349-2356.
43. 3. J Biomed Mater Res 1998; 41: 489-496.
44. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 1990; 143: 213-221.
45. Ramírez-Zacarias JL, Castro-Muñozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 1992; 97: 493-497.
46. Beck GR. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 2003; 90: 234-243.
47. Sudo H, Kodama H-A, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96: 191-198.
48. 2 synthesis in the clonal osteoblast-like cell line MC3 T3-E1. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 121-125.
49. 2-dependent pathway. Oral Dis 2006; 13: 32-39.
50. Smith WL. Prostanoid biosynthesis and mechanism of action. Am J Physiol 1992; 263: F91-F181.
51. 2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J Cell Biochem 1999; 73: 36-48.
52. Fujimori A, Tsutsumi M, Fukase M, Fujita T. Cyclooxygenase inhibitors enhance cell growth in an osteoblastic cell line, MC3 T3-E1. J Bone Miner Res 1989; 4: 697-704.
53. 2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch Oral Biol 1999; 44: 233-241.
54. Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004; 39: 1125-1132.
55. Zhi J, Sommerfeldt DW, Rubin CT, Hadjiargyrou M. Differential expression of neuroleukin in osseous tissues and its involvement in mineralization during osteoblast differentiation. J Bone Miner Res 2001; 16: 1994-2004.
56. Lecka-Czernik B, Gubrij I, Moerman EJ, et al. Inhibition of Osf2/ Cbfa1 expression and terminal osteoblast differentiation by PPARy2. J Cell Biochem 1999; 74: 357-371.
57. Akune T, Ohba S, Kamekura S, et al. PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004; 113: 846-855.
58. Shin C, Kim S, Her S, Kim D, Kim S. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Bone 2005; 36: S286.